MarketPulse

atirmociclib

4 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Relay Therapeutics

Relay Therapeutics Advances Breast Cancer Drug Combo Toward Phase 3 Trial

Relay Therapeutics reports positive Phase 2 data for zovegalisib triplet combination in metastatic breast cancer, planning Phase 3 launch in early 2027.
PFERLAYPhase 3 trialzovegalisib
BenzingaBenzinga··Vandana Singh

Pfizer's Dual Cancer Wins Boost Stock as Prostate, Breast Trials Succeed

Pfizer shares rise on Phase 3 prostate cancer trial win and Phase 2 breast cancer success, validating its oncology pipeline and signaling near-term regulatory catalysts.
PFEbreast cancerPhase 3 trial
BenzingaBenzinga··Vandana Singh

Pfizer's Breast Cancer Drug Hits Survival Goals as Oncology Pipeline Accelerates

Pfizer reports positive Phase 2 data for atirmociclib in metastatic breast cancer, meeting survival endpoints. Company also gains FDA approval for Braftovi in colorectal cancer.
PFEcolorectal cancerFDA approval
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Olema Oncology Advances Breast Cancer Pipeline, Secures $218.5M in Funding

Olema reported strong trial progress for palazestrant in breast cancer, raised $218.5M, and expects pivotal data in fall 2026.
PFEOLMAPhase 3 trialsclinical development